Maternal and fetal antibrain antibodies in development and disease
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Recent evidence has emerged indicating that the maternal immune response can have a substantial deleterious impact on prenatal development (Croen et al., [2008]: Biol Psychiatry 64:583‐588). The maternal immune response is largely sequestered from the fetus. Maternal antibodies, specifically immunoglobulin G (IgG), are passed to the fetus to provide passive immunity throughout much of pregnancy. However, both protective and pathogenic autoantibodies have equal access to the fetus (Goines and Van de Water [2010]: Curr Opin Neurol 23:111‐117). If the mother has an underlying autoimmune disease or has reactivity to fetal antigens, autoantibodies produced before or during pregnancy can target tissues in the developing fetus. One such tissue is the fetal brain. The blood brainbarrier (BBB) is developing during the fetal period allowing maternal antibodies to have direct access to the brain during gestation (Diamond et al. [2009]: Nat Rev Immunol; Braunschweig et al. [2011]; Neurotoxicology 29:226‐231). It has been proposed that brain injury by circulating brain–specific maternal autoantibodies might underlie multiple congenital, developmental disorders (Lee et al. [2009]: Nat Med 15:91‐96). In this review, we will discuss the current state of research in the area of maternal autoantibodies and the development of autism. © 2012 Wiley Periodicals, Inc. Develop Neurobiol, 2012
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Placental transport of immunoglobulin G
Simister, N. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00334-7 · Cited by 783
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.025 · Cited by 279 · cited 1×
“Autism spectrum disorder is a heterogeneous group of neurodevelopmental disorders that manifest in early childhood and are characterized by impairments in social interaction, verbal and nonverbal communication, and stereotyped behaviors and circumscribed interests (Ashwood et al., 2011).”
BackgroundLosing your nerves? Maybe it's the antibodies
Diamond, B., Huerta, P. T., Mina-Osorio, P., Kowal, C., & Volpe, B. T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2529 · Cited by 247
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism
Martin, L. A., Ashwood, P., Braunschweig, D., Cabanlit, M., Van de Water, J., & Amaral, D. G. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.007 · Cited by 231 · cited 2×
“Rhesus monkeys prenatally exposed to this pool of maternal antibodies produced more whole body motor stereotypies and hyperactivity compared to both untreated control monkeys and monkeys prenatally exposed to IgG class antibodies from mothers of typically developing children (Martin et al., 2008).”
BackgroundSelf-citationMaternal neuronal antibodies associated with autism and a language disorder
Dalton, P., Deacon, R., Blamire, A., Pike, M., McKinlay, I., Stein, J., Styles, P., & Vincent, A. (2003) · Annals of Neurology · doi:10.1002/ana.10557 · Cited by 204 · cited 3×
“Plasma from one mother of multiple children with autism was injected into pregnant mice and the offspring demonstrated impaired exploratory behavior and motor coordination (Dalton et al., 2003; studies summarized in Table 1).”
BackgroundMethodVojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00180-7 · Cited by 197
Maternal antibrain antibodies in autism
Zimmerman, A. W., Connors, S. L., Matteson, K. J., Lee, L.-C., Singer, H. S., Castaneda, J. A., & Pearce, D. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.005 · Cited by 190 · cited 7×
“The production of anti-brain antibodies may be the result of a maternal immune reaction to fetal antigens during pregnancy (Silva et al., 2004; Zimmerman et al., 2007; Heuer et al., 2011).”
BackgroundInfluentialBauman, M. D., Iosif, A.-M., Ashwood, P., Braunschweig, D., Lee, A., Schumann, C. M., Van de Water, J., & Amaral, D. G. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.47 · Cited by 174
Self-citationPlacental transfer of immunoglobulin G subclasses
Garty, B. Z., Ludomirsky, A., Danon, Y. L., Peter, J. B., & Douglas, S. D. (1994) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.6.667-669.1994 · Cited by 165 · cited 1×
“Most antibodies are acquired during the third trimester and IgG levels in full-term infants often exceed those in the maternal circulation (Garty et al., 1994; Simister, 2003).”
BackgroundSinger, H. S., Morris, C., Gause, C., Pollard, M., Zimmerman, A. W., & Pletnikov, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.011 · Cited by 164 · cited 2×
“Brain-reactive antibodies have been observed in mature patients with several neurological and psychiatric disorders and in healthy individuals (Diamond et al., 2009; Singer et al., 2009).”
Background
Cited by
Prenatal factors associated with autism spectrum disorder (ASD)
Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.05.007 · Cited by 238
“One of the mechanisms is immune dysregulation that ncludes abnormal levels of cytokines and growth factors, fetal and aternal antibodies to brain tissue [16,17], microglial activation, bnormal numbers of CD4 and CC8 cells and a variety of antibodes [21].”
BackgroundMarques, A. H., O'Connor, T. G., Roth, C., Susser, E., & Bjørke-Monsen, A.-L. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00120 · Cited by 226
“It has been proposed that brain-specific maternal autoantibodies might underlie multiple congenital and neurodevelopmental disorders (for review see Billington, 1992; Lee et al., 2009; Fox et al., 2012).”
BackgroundMarques, A. H., Bjørke-Monsen, A.-L., Teixeira, A. L., & Silverman, M. N. (2015) · Brain Research · doi:10.1016/j.brainres.2014.10.051 · Cited by 166
The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness
Hornig, M. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32836208de · Cited by 138
Immune Dysregulation in Autism Spectrum Disorder
Hsiao, E. Y. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00009-5 · Cited by 87
Camacho, J., Jones, K., Miller, E., Ariza, J., Noctor, S., Van de Water, J., & Martínez-Cerdeño, V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.045 · Cited by 49
“transfer have been described for autoimmune diseases such as systemic lupus erythematosus, transient neonatal myasthenia gravis, and others [11].”
Background
Metadata
- Authors
- Fox, E., Amaral, D., & Van de Water, J.
- Venue
- Developmental Neurobiology
- Publisher
- Wiley
- Published
- 2012-09-04
- Volume
- 72
- Issue
- 10
- Pages
- 1327-1334
- ISSN
- 1932-8451 (ISSN-L)
- 1932-846X
- OpenAlex
- W1971194689
- Cited by
- 64
- References
- 17
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.